Pasithea Therapeutics Corp. (KTTAW) Income from Discontinued Operations (2022 - 2023)
Pasithea Therapeutics' (KTTAW) quarterly Income from Discontinued Operations came in at -$81943.0 in Q4 2023, up 97.6% year-over-year from -$41468.7 in Q4 2022, and up 50.38% quarter-over-quarter from -$165146.0 in Q2 2023.
Powered by 
Analysis
Pasithea Therapeutics Corp. (KTTAW) Income from Discontinued Operations (2022 - 2023) Analysis & Trends
Pasithea Therapeutics has disclosed Income from Discontinued Operations across 2 years of filings, most recently posting -$81943.0 for Q4 2023.
- In Q4 2023, Income from Discontinued Operations rose 97.6% year-over-year to -$81943.0; the TTM figure through Dec 2023 stood at -$518958.0 (up 86.4% YoY), while the FY2023 annual figure was -$518958.0, up 76.7% from the prior year.
- Income from Discontinued Operations came in at -$81943.0 for Q4 2023 at Pasithea Therapeutics, up from -$165146.0 in the prior quarter.
- In the past five years, Income from Discontinued Operations ranged from a high of $395089.0 in Q3 2022 to a low of -$3.4 million in Q4 2022.
Peer Set
Peer Comparison
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2023 | -81,943.00 |
| Jun 30, 2023 | -165,146.00 |
| Mar 31, 2023 | -271,869.00 |
| Dec 31, 2022 | -3.42 Mn |
| Sep 30, 2022 | 395,089.00 |
| Jun 30, 2022 | -468,535.00 |
| Mar 31, 2022 | -325,659.00 |